Curida Diatec Is A Norwegian Biotechnology Company That Specializes In Antibody Production And Conjugationestablished After Curida S Acquisition Of Diatec Monoclonals In 2022The Company Has Over 25 Years Of Experience In The Biotechnology Sectorparticularly In Monoclonal Antibodiescurida Diatec Is Committed To Supporting The Pharmaceutical Industry With A Range Of Servicesincluding The Development Of Monoclonal Antibodiesprocess Developmentquality Controland Regulatory Support The Company Operates From Its Headquarters And Manufacturing Site At Technopolis In Fornebunorwaywhich Features A Flexible Production Unit And Analytical Laboratoriescurida Diatec Also Has A Presence In The Norwegian Market Through Its A S Produksjonslab Facilitywith A Focus On High Quality Products And Servicescurida Diatec Positions Itself As A Reliable Partner For Pharmaceutical Companies Looking To Advance Their Research And Product Development
